RNA splicing modulation as a precision approach for neuroendocrine cancer treatment

Cy­to­ki­net­ics CEO Robert Blum blamed in­vestor frus­tra­tion over a deal with Roy­al­ty Phar­ma on a “hi­jacked” nar­ra­tive that the com­pa­ny would be bet­ter off sell­ing

The CHMP has issued a positive opinion for Sandoz’s Tysabri biosimilar. Credit: Shutterstock / Konektus Photo. The European Medicines Agency’s (EMA) Committee for Medicinal Products

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. USAID Takedown May Be Illegal The